LABD vs. GGLL

Last updated Jun 24, 2026

LABD (Direxion Daily S&P Biotech Bear 3x Shares) and GGLL (Direxion Daily GOOGL Bull 2X Shares) are both Leveraged Equities funds from Direxion - LABD tracks the S&P Biotechnology Select Industry Index (-300%) while GGLL tracks the Alphabet Inc. Class A (200%). Both are passively managed. Over the past 3 years, LABD returned -56.99%/yr vs 62.75%/yr for GGLL. At a correlation of -0.30, they often move in opposite directions. LABD charges 1.06%/yr vs 0.96%/yr for GGLL.

Performance

LABD vs. GGLL - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Direxion Daily GOOGL Bull 2X Shares (GGLL). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

In the year-to-date period, LABD achieves a -53.78% return, which is significantly lower than GGLL's 11.40% return.

LABD

• 1D: -3.10%
• 1M: -32.29%
• YTD: -53.78%
• 6M: -50.39%
• 1Y: -87.04%
• 3Y*: -56.99%
• 5Y*: -43.25%
• 10Y*: -59.09%

GGLL

• 1D: -2.70%
• 1M: -20.13%
• YTD: 11.40%
• 6M: 10.14%
• 1Y: 265.53%
• 3Y*: 62.75%
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

LABD vs. GGLL - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022
LABD Direxion Daily S&P Biotech Bear 3x Shares	-53.78%	-70.07%	-21.43%	-41.77%	-28.16%
GGLL Direxion Daily GOOGL Bull 2X Shares	11.40%	123.07%	48.88%	81.20%	-30.35%

Correlation

The correlation between LABD and GGLL is -0.29, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.

	Correlation
Correlation (1Y) Calculated over the trailing 1-year period	-0.29
Correlation (3Y) Calculated over the trailing 3-year period	-0.28
Correlation (All Time) Calculated using the full available price history since Sep 7, 2022	-0.30

Return for Risk

LABD vs. GGLL — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LABD

LABD Risk / Return Rank: 1
LABD Sharpe Ratio Rank: 1
LABD Sortino Ratio Rank: 0
LABD Omega Ratio Rank: 0
LABD Calmar Ratio Rank: 0
LABD Martin Ratio Rank: 2

GGLL

GGLL Risk / Return Rank: 94
GGLL Sharpe Ratio Rank: 97
GGLL Sortino Ratio Rank: 94
GGLL Omega Ratio Rank: 90
GGLL Calmar Ratio Rank: 94
GGLL Martin Ratio Rank: 93

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LABD vs. GGLL - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Direxion Daily GOOGL Bull 2X Shares (GGLL). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	LABD	GGLL	Difference
Sharpe ratio: Return per unit of total volatility	-1.11	4.51	-5.62
Sortino ratio: Return per unit of downside risk	-2.73	4.55	-7.28
Omega ratio: Gain probability vs. loss probability	0.70	1.55	-0.85
Calmar ratio: Return relative to maximum drawdown	-1.00	6.97	-7.97
Martin ratio: Return relative to average drawdown	-1.37	22.42	-23.79

LABD vs. GGLL - Sharpe Ratio Comparison

The current LABD Sharpe Ratio is -1.11, which is lower than the GGLL Sharpe Ratio of 4.51. The chart below compares the historical Sharpe Ratios of LABD and GGLL, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.

Drawdowns

LABD vs. GGLL - Drawdown Comparison

The maximum LABD drawdown since its inception was -99.99%, which is greater than GGLL's maximum drawdown of -52.81%. Use the drawdown chart below to compare losses from any high point for LABD and GGLL.

Drawdown Indicators

	LABD	GGLL	Difference
Max Drawdown Largest peak-to-trough decline	-99.99%	-52.81%	-47.18%
Max Drawdown (1Y) Largest decline over 1 year	-86.75%	-38.39%	-48.36%
Max Drawdown (3Y) Largest decline over 3 years	-96.40%	-52.81%	-43.59%
Max Drawdown (5Y) Largest decline over 5 years	-98.65%	—	—
Max Drawdown (10Y) Largest decline over 10 years	-99.99%	—	—
Current Drawdown Current decline from peak	-99.99%	-28.02%	-71.97%
Average Drawdown Average peak-to-trough decline	-90.99%	-15.22%	-75.77%
Ulcer Index Depth and duration of drawdowns from previous peaks	64.00%	11.91%	+52.09%

Volatility

LABD vs. GGLL - Volatility Comparison

Direxion Daily S&P Biotech Bear 3x Shares (LABD) has a higher volatility of 29.98% compared to Direxion Daily GOOGL Bull 2X Shares (GGLL) at 19.04%. This indicates that LABD's price experiences larger fluctuations and is considered to be riskier than GGLL based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	LABD	GGLL	Difference
Volatility (1M) Calculated over the trailing 1-month period	29.98%	19.04%	+10.94%
Volatility (6M) Calculated over the trailing 6-month period	65.23%	42.25%	+22.98%
Volatility (1Y) Calculated over the trailing 1-year period	78.79%	59.29%	+19.50%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	96.66%	56.23%	+40.43%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	95.97%	56.23%	+39.74%

LABD vs. GGLL - Expense Ratio Comparison

LABD has a 1.06% expense ratio, which is higher than GGLL's 0.96% expense ratio.

Dividends

LABD vs. GGLL - Dividend Comparison

LABD's dividend yield for the trailing twelve months is around 9.79%, more than GGLL's 4.10% yield.

Position	TTM	2025	2024	2023	2022	2021	2020	2019	2018
GGLL Direxion Daily GOOGL Bull 2X Shares	4.10%	4.16%	3.29%	2.05%	0.59%	0.00%	0.00%	0.00%	0.00%
LABD Direxion Daily S&P Biotech Bear 3x Shares	9.79%	6.67%	4.68%	6.13%	0.53%	0.00%	3.94%	1.75%	0.81%

Frequently Asked Questions

Can I hold both LABD and GGLL in my portfolio?

LABD and GGLL have a correlation of -0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Which is riskier, LABD or GGLL?

LABD has higher volatility (29.98%) compared to GGLL (19.04%). In terms of maximum drawdown, LABD dropped -99.99% vs GGLL's -52.81%.

Which ETF is better, LABD or GGLL?

On 3-year performance, GGLL leads with 62.75% vs -56.99% for LABD. On fees, GGLL is cheaper at 0.96% per year. On volatility, GGLL has been the lower-risk option at 19.04%. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF has performed better, LABD or GGLL?

Over the 3-year period, GGLL has performed better with a 62.75% return vs -56.99%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.

Which ETF is cheaper, LABD or GGLL?

GGLL is cheaper with a 0.96% expense ratio, compared with 1.06% for LABD.

Which ETF pays a higher dividend yield, LABD or GGLL?

LABD has the higher dividend yield at 9.79%, compared with 4.10% for GGLL.

What is the main difference between LABD and GGLL?

LABD tracks S&P Biotechnology Select Industry Index (-300%), while GGLL tracks Alphabet Inc. Class A (200%). Their fees differ too: 1.06% for LABD and 0.96% for GGLL.

Which has better risk-adjusted returns?

GGLL currently has the higher Sharpe Ratio (4.51 vs -1.11), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.